TREATMENT OF EGFR DEPENDENT TUMORS BY ABIN (A20-BINDING INHIBITOR OF NF KAPPAB)
摘要
<p>The present invention relates to the treatment of epidermal growth factor-family receptor (ErbB) dependent tumours. More specifically, the present invention relates to the use of ABIN for the preparation of a medicament to inhibit epidermal growth factor (EGF) induced proliferation, and to treat ErbB-dependent tumours.</p>
